Strata Critical Medical, Inc. (SRTA): Capital Expenditures
$9.60M
Year ended 2025-12-31
+136.0%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.60M | -68.9% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $30.86M | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $2.11M | +188.9% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $730.0K | n/a | 2024-03-12, From 2022-01-01 |
| No annual figure between 2021-09-30 and 2022-12-31. | |||
| 2021-09-30 | $297.0K | -21.2% | 2023-03-16, From 2020-10-01 |
| 2020-09-30 | $377.0K | -37.6% | 2021-12-20, From 2019-10-01 |
| 2019-09-30 | $604.0K | n/a | 2021-12-20, From 2018-10-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $9.60M | -68.9% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $1.32M | +121.8% |
| DocGo Inc. (DCGO) | 2025-12-31 | $4.54M | +25.8% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $19.02M | +246.3% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $14.07M | +53.2% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $12.04M | +33.9% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $14.31M | +128.5% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $36.12M | +67.5% |
| P3 Health Partners Inc. (PIII) | 2024-12-31 | $0 | -100.0% |
Compare SRTA, OMDA, DCGO, WGS side by side · Screen every company in Services-Health Services ↗